A phase II irinotecan–cisplatin combination in advanced pancreatic cancer

por Markham, C, Stocken, D D, Hassan, A B
Publicado 2003

Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients

por Hurst, N G, Stocken, D D, Wilson, S, Keh, C, Wakelam, M J O, Ismail, T
Publicado 2007

Reply: Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients

por Hurst, N G, Stocken, D D, Wilson, S, Keh, C, Wakelam, M J O, Ismail, T
Publicado 2008

Modelling prognostic factors in advanced pancreatic cancer

por Stocken, D D, Hassan, A B, Altman, D G, Billingham, L J, Bramhall, S R, Johnson, P J, Freemantle, N
Publicado 2008

Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer

por Hussain, S A, Stocken, D D, Peake, D R, Glaholm, J G, Zarkar, A, Wallace, D M A, James, N D
Publicado 2004

A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer

por Hussain, S A, Stocken, D D, Riley, P, Palmer, D H, Peake, D R, Geh, J I, Spooner, D, James, N D
Publicado 2004

Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test

por Wilson, S, Damery, S, Stocken, D D, Dowswell, G, Holder, R, Ward, S T, Redman, V, Wakelam, M J, James, J, Hobbs, F D R, Ismail, T
Publicado 2012

TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis

por Cole, M., Yap, C., Buckley, C., Ng, W. F., McInnes, I., Filer, A., Siebert, S., Pratt, A., Isaacs, J. D., Stocken, D. D.
Publicado 2021

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer

por Stocken, D D, Büchler, M W, Dervenis, C, Bassi, C, Jeekel, H, Klinkenbijl, J H G, Bakkevold, K E, Takada, T, Amano, H, Neoptolemos, J P
Publicado 2005

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

por Neoptolemos, J P, Stocken, D D, Tudur Smith, C, Bassi, C, Ghaneh, P, Owen, E, Moore, M, Padbury, R, Doi, R, Smith, D, Büchler, M W
Publicado 2009